Covishield Current Affairs, GK & News

Bharat Biotech Nasal Booster Trials

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the strength to fight against the third wave that is violently spreading the Omicron. About the ..

Month: 

Category: 

Topics: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional market authorisation? The Serum Institute vaccine COVISHELD and Bharat Biotech’s COVAXIN were administered in the ..

Month: 

Category: 

Topics: 

Precautionary vaccine jabs in India

The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health care workers, comorbid patients (people with severe medical conditions) and frontline workers are eligible to get the precaution dose. Five states in the country are to go ..

Month: 

Category: 

Topics: 

WHO’s medical alert on fake Covishield Vaccines

World Health Organisation (WHO) issued medical alerts on fake Covishield Vaccines in India. Key Points WHO has raised doubts on the genuineness of Covishield which is reaching patients in India. India is reporting circulation of fake vials of the covid-19 vaccine that has been developed by Oxford-AstraZeneca while manufactured by Serum Institute of India (SII). ..

Month: 

Category: 

Topics: 

Cyrus Poonawala to receive Lokmanya Tilak Award

The founder of the Serum Institute of India (SII) in Pune, businessman Cyrus Poonawalla has been named the winner of the prestigious National Lokmanya Tilak Award 2021. Highlights He will be commended for his work during the COVID-19 pandemic and how his company helped save many lives by creating the Covishield vaccine and then making ..

Month: 

Category: 

Topics: 

ZyCoV-D: World’s first DNA-based Vaccine

Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the world’s first DNA-based vaccine. With this, the number of vaccines available in the country will increase to 4. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and ..

Month: 

Category: 

Topics: